Fulvestrant (Faslodex) Chemical Structure
A selective estrogen receptor modulator(SERM). raloxifene inhibited the proliferation of the human breast cancer cell line, MCF-7, with IC50=0.2 nM
Dienogest is an orally active synthetic progesterone (or progestin).
LY500307 (SERBA-1) is a potent, selective estrogen receptor β agonist with an EC50 of 0.66 nM.
Hexestrol(Bibenzyl) is a novel type of 17βhydroxysteroid dehydrogenase, AKR1C1and AKR1C2 potent inhibitor with IC50 of 0.8, 9.5, 2.8 µM, respectively and exhibits strong affinity for estrogen receptors.
Andarine (GTX-007) is an investigational selective androgen receptor modulator (SARM) and an active partial agonist.
An androgen receptor modulator (SARM)
Anastrozole inhibits the enzyme aromatase.
Exemestane was found to inhibit human placental aromatase with IC50 of 42 nM.
Finasteride is an inhibitor of steroid Type II 5α-reductase.
Dutasteride is a 5-alpha-reductase inhibitor
Fulvestrant (Faslodex) is a synthetic estrogen receptor antagonist or selective estrogen receptor down-regulator (SERD). Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. [1] Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. [2]
| Molecular Weight (WM): | 606.77 |
|---|---|
| Formula: | C32H47F5O3S |
| CAS No.: | 129453-61-8 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥121mg/mL |
| Water <1mg/mL | |
| Ethanol ≥121mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
A collection of 864 bioactive compounds
A collection of 481 inhibitors
A collection of 194 kinase inhibitors
A collection of 85 tyrosine kinase inhibitors.
A collection of 426 FDA approved drugs
A collection of 139 natural products
A collection of 40 chemotherapeutic agents
A unique collection of 17 small molecule modulators
A unique collection of 47 small molecule inhibitors
A unique collection of 63 GPCR small molecules
Keywords:buy Fulvestrant (Faslodex) | Fulvestrant (Faslodex) supplier | purchase Fulvestrant (Faslodex) | Fulvestrant (Faslodex) cost | Fulvestrant (Faslodex) manufacturer | order Fulvestrant (Faslodex) | Fulvestrant (Faslodex) distributor